CHLOR-TRIMETON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chlor-trimeton, and when can generic versions of Chlor-trimeton launch?
Chlor-trimeton is a drug marketed by Schering Plough, Schering, and Bayer Healthcare Llc. and is included in five NDAs.
The generic ingredient in CHLOR-TRIMETON is chlorpheniramine maleate; pseudoephedrine sulfate. There are twenty-nine drug master file entries for this compound. Additional details are available on the chlorpheniramine maleate; pseudoephedrine sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHLOR-TRIMETON?
- What are the global sales for CHLOR-TRIMETON?
- What is Average Wholesale Price for CHLOR-TRIMETON?
Summary for CHLOR-TRIMETON
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 46 |
| Clinical Trials: | 1 |
| Patent Applications: | 6,416 |
| DailyMed Link: | CHLOR-TRIMETON at DailyMed |
Recent Clinical Trials for CHLOR-TRIMETON
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Auburn University | Early Phase 1 |
US Patents and Regulatory Information for CHLOR-TRIMETON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering Plough | CHLOR-TRIMETON | chlorpheniramine maleate | INJECTABLE;INJECTION | 008826-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Schering | CHLOR-TRIMETON | chlorpheniramine maleate | TABLET;ORAL | 006921-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bayer Healthcare Llc | CHLOR-TRIMETON | chlorpheniramine maleate; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 018397-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
